Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. Takes Inspection Appeal To WHO

This article was originally published in PharmAsia News

Executive Summary

On the heels of signing two memoranda of understanding with China, the United States says it wants an international certification system for imported products. Health and Human Services Secretary Mike Leavitt signed the memoranda during a recent trip to China, requiring China to strengthen its own safety checks on drug supplies. Speaking to the annual assembly of the World Health Organization in Geneva, Leavitt said no nation could ensure the safety of imported products by inspecting at its borders. Instead, they rely on a "collaborative system of international standards and local controls." (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068541

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel